首页> 外文期刊>Osteoarthritis and cartilage >Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model.
【24h】

Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model.

机译:直接延迟人腺病毒BMP-2或BMP-6基因治疗在小马骨软骨模型中的骨骼和软骨再生。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To evaluate healing of surgically created large osteochondral defects in a weight-bearing femoral condyle in response to delayed percutaneous direct injection of adenoviral (Ad) vectors containing coding regions for either human bone morphogenetic proteins 2 (BMP-2) or -6. METHODS: Four 13mm diameter and 7mm depth circular osteochondral defects were drilled, 1/femoral condyle (n=20 defects in five ponies). At 2 weeks, Ad-BMP-2, Ad-BMP-6, Ad-green fluorescent protein (GFP), or saline was percutaneously injected into the central drill hole of the defect. Quantitative magnetic resonance imaging (qMRI) and computed tomography (CT) were serially performed at 12, 24, and 52 weeks. At 12 (one pony) or 52 weeks, histomorphometry and microtomographic analyses were performed to assess subchondral bone and cartilage repair tissue quality. RESULTS: Direct delivery of Ad-BMP-6 demonstrated delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and histologic evidence of greater Glycosaminoglycan (GAG) content in repair tissue at 12 weeks, while Ad-BMP-2 had greater non-mineral cartilage at the surface at 52 weeks (p<0.04). Ad-BMP-2 demonstrated greater CT subchondral bone mineral density (BMD) by 12 weeks and both Ad-BMP-2 and -6 had greater subchondral BMD at 52 weeks (p<0.05). Despite earlier (Ad-BMP-6) and more persistent (Ad-BMP-2) chondral tissue and greater subchondral bone density (Ad-BMP-2 and -6), the tissue within the large weight-bearing defects at 52 weeks was suboptimal in all groups due to poor quality repair cartilage, central fibrocartilage retention, and central bone cavitation. Delivery of either BMP by this method had greater frequency of subchondral bone cystic formation (p<0.05). CONCLUSIONS: Delivery of Ad-BMP-2 or Ad-BMP-6 via direct injection supported cartilage and subchondral bone regeneration but was insufficient to provide long-term quality osteochondral repair.
机译:目的:评估因经皮经皮直接直接注射包含人类骨形态发生蛋白2(BMP-2)或-6编码区的腺病毒(Ad)载体而引起的负重股骨dy中手术产生的大型骨软骨缺损的愈合。方法:钻出四个直径13mm,深度7mm的圆形骨软骨缺损,每个股骨con 1个(五个小马中n = 20个缺损)。在第2周,将Ad-BMP-2,Ad-BMP-6,Ad-绿色荧光蛋白(GFP)或盐水经皮注射到缺损的中央钻孔中。在第12、24和52周连续进行定量磁共振成像(qMRI)和计算机断层扫描(CT)。在第12周(一头小马)或52周时,进行了组织形态计量学和显微断层扫描分析,以评估软骨下骨和软骨修复组织的质量。结果:Ad-BMP-6的直接递送证明了delayed增强的MRI软骨(dGEMRIC)以及组织学证据表明,在12周时修复组织中糖胺聚糖(GAG)含量更高,而Ad-BMP-2的非矿物软骨含量更高。在第52周的表面(p <0.04)。 Ad-BMP-2在12周时显示出更高的CT软骨下骨矿物质密度(BMD),而Ad-BMP-2和-6在52周时均具有更高的软骨下BMD(p <0.05)。尽管早期(Ad-BMP-6)和更持久(Ad-BMP-2)的软骨组织和更大的软骨下骨密度(Ad-BMP-2和-6),但52周大负重缺陷内的组织仍在所有组中,由于修复软骨质量差,中央纤维软骨retention留和中央骨空化而导致次优。通过这种方法递送任何一种BMP的软骨下骨囊性形成的频率更高(p <0.05)。结论:通过直接注射支持软骨和软骨下骨再生来递送Ad-BMP-2或Ad-BMP-6,但不足以提供长期优质的骨软骨修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号